Connect with us

Hi, what are you looking for?


US FDA Approves First COVID-19 Treatment For Young Children

COVID-19 treatment

LOS ANGELES, April 26 (Bernama) — The US Food and Drug Administration (FDA) on Monday expanded its approval of the COVID-19 treatment Veklury, also known as remdesivir, to include pediatric patients 28 days of age and older weighing at least 3 kilogrammes who are infected by SARS-CoV-2.

This action makes Veklury the first approved COVID-19 treatment for children less than 12 years of age, said the FDA.

Veklury is approved for young children who are hospitalised, or have mild-to-moderate COVID-19 and are at high risk for progression to severe COVID-19, according to the FDA, said Xinhua.

Previously Veklury was only approved to treat COVID-19 for certain adults and pediatric patients 12 years of age and older who weigh at least 40 kg.

“As COVID-19 can cause severe illness in children, some of whom do not currently have a vaccination option, there continues to be a need for safe and effective COVID-19 treatment options for this population,” said Patrizia Cavazzoni, director of the FDA’s Centre for Drug Evaluation and Research.

Sources: BERNAMA

You May Also Like


The Chinese government has lockdown Zhengzhou city, home to the world’s largest iPhone manufacture, due to the widespread spread of the coronavirus. The closure,...


On Sunday, a man and his wife died after going into the water at a dyke in Khao Chai Son district of Thailand in...


WHO and MOH worked together to use behavioral science for health communications. Many countries are now moving towards a sustained management approach after the...


Ezra Miller, the troubled star of Warner Bros’ major upcoming superhero movie “The Flash,” is seeking treatment for mental health issues after a string...


Copyright © 2021 Siakap Keli Sdn. Bhd.